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Abstract
Background: Theodor Kocher, surgeon and Nobel laureate, has influenced thyroid surgery all over
the world: his treatment for multinodular goiter—subtotal thyroidectomy—has been the ‘‘Gold
Standard’’ for more than a century. However, based on a new understanding of molecular growth
mechanisms in goitrogenesis, we set out to evaluate if a more extended resection yields better
results.
Methods: Four thousand three hundred and ninety-four thyroid gland operations with 5,785
‘‘nerves at risk’’ were prospectively analyzed between 1972 and 2002. From 1972 to 1990, the
limited Kocher resections were performed, and from 1991 to 2002 a more radical resection
involving at least a hemithyroidectomy was performed.
Results: The incidence of postoperative nerve palsy was 3.6% in the first study period and 0.9% in
the second (P < 0.001, Fishers exact). Postoperative hypoparathyroidism decreased from 3.2%
in the first period to 0.64% in the second (P < 0.01). The rate of reoperation for recurrent disease
was 11.1% from 1972 to 1990 and 8.5% from 1991 to 2002 (P < 0.01).
Conclusions: Extended resection for multinodular goiter not only significantly reduced morbidity,
but also decreased the incidence of operations for recurrent disease. Our findings in a large cohort
corroborate the suggestions that Kochers approach should be replaced by a more radical
resection, which actually was his original intention more than 130 years ago.
I n 1883, Theodor Kocher, then chairman of theDepartment of Surgery at the University of Bern,
warned about the perils of radical thyroid surgery in a
paper entitled: ‘‘On extirpation of the goiter and its se-
quelae’’.1–6 In this publication, based on over 100 very
accurately documented cases, he recommended only
performing subtotal resections in order to avoid hypo-
thyroidism, recurrent laryngeal nerve palsy, and hypo-
parathyroidism (which in those days was not very well
known or understood).1 Based on this experience, sub-
total thyroidectomies or nodal enucleations became the
‘‘criterion standard’’ of goiter surgery and were performed
all over the world over the next 100 years.7 In Kochers
day, Switzerland was faced with a staggering goiter epi-
demic: an impressive 35% of the children in first grade
and 79% of the children in ninth grade suffered from
significant goiter disease.8–11 Kochers innovative
understanding of this epidemiologic problem led him to
the hypothesis that iodine deficiency was the etiology of
goiter disease. He, therefore, advocated the addition of
iodine to table salt in Switzerland, which was begun under
governmental control in 1922. The result of this ingenious
initiative—for which Kocher was awarded the Nobel
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prize—was an impressive drop in the incidence of goiter
disease in this country. Thus, iodine deficiency has not
been prevalent in Switzerland for over 80 years,12 unlike
other European countries that have iodine-deficient re-
gions. It offers, therefore, a ‘‘laboratory-like’’ ground for
clinical and epidemiologic research.
However, reviewing data on thyroid surgery prospec-
tively collected from 1972 to 1990, we realized that still a
large number of goiters needed surgical treatment and
that the incidence of postoperative recurrent thyroid dis-
ease is high (11%). Morbidity associated with this surgery
is not negligible: of the referred patients with recurrent
disease the preoperative permanent recurrent laryngeal
nerve palsy rate (19.2%) was forbiddingly high. At our
institution the recurrent laryngeal nerve palsy rate was
3.6% at the initial operation and 5.2% at reoperation, and
the incidence of postoperative hypoparathyroidism was
3.2%. This, and improved surgical infrastructure com-
pared with Kochers days is why we performed a more
extensive approach to thyroid disease after 1990, which
demanded the visualization of the recurrent laryngeal
nerve and the parathyroid glands. In the present study we
wanted to evaluate whether the more extensive goiter
resection resulted in more surgery-associated morbidity
and/or a decrease in goiter recurrence.
We reviewed our prospectively collected data on all
thyroid gland surgeries at our institution from 1972 to
2002 and compared the period from 1972 to 1990, when
we were operating according to the Kocher concept of
thyroid surgery, with the period from 1991 to 2002,
when—based on a new understanding of goitrogene-
sis—a more extended surgical approach was used. The
primary goal of this study was to determine whether the
more extensive surgical approach improves the short-
and long-term outcome of thyroidectomy and can safely
be recommended.
PATIENTS AND METHODS
This study is a single institutional non-concurrent cohort
study of 4,349 goiter operations (corresponding to 5,785
‘‘nerves at risk’’) performed at the University Hospital of
Bern, Switzerland. All patients undergoing a goiter oper-
ation at this institution between 1972 and 2002 were in-
cluded in the study and prospectively followed for the
recurrence of laryngeal nerve lesions by direct laryngos-
copy, which was performed in all patients before and after
surgery and followed over 1 year by independent ENT
specialists (loss to follow-up was 1%). Since in the
present study operative morbidity was the primary out-
come, we included all (benign and malignant) pathologies
that led to thyroid surgery. Over the whole study period,
patient and operative data were collected prospectively
and analyzed retrospectively for transitory and permanent
recurrent laryngeal nerve palsy, hypoparathyroidism, and
recurrence of goiter disease. Preoperative evaluation
during the whole study period included history, clinical
evaluation, scintigraphy and/or sonography, FNA in most
of the cases, and thyroid hormone status. The indications
for the initial operation are listed in Table 1. The indica-
tion for surgery was benign nodular goiter in 66%,
hyperthyroidism in 20%, and malignancy in 14%. Of the
4,349 operations, 445 were performed for recurrent goiter
disease. In 78% of these 445 patients, the indication for
reoperation was recurrent benign, euthyroitic, nodular
goiter disease, associated, in particular, with compressive
symptoms, rapid thyroid growth, or concern due to
malignant alteration. The other 22% of recurrences were
due to malignancy (16%) and hyperthyroidism (6%). Pa-
tients undergoing operation had to be euthyroid on the
day of surgery. Table 2 shows the yearly rate of opera-
tions of the patients in the 2 study periods stratified in key
indications. The basic demographic data did not differ
between the groups (data not shown). In addition, no
difference between the 2 cohorts could be detected for
demographic data relevant to thyroid disease—the yearly
rate of thyroid surgery and the proportion of the various
indications for thyroid surgery. Referral patterns remained
the same over the study period. Interventions for benign
nodular goiter remained between 66% and 63% over the
whole study period. The rate of hyperthyroidism leading
to thyroid surgery was 21% in the first study period
and 20% in the second. Further subgroup analysis for
hyperthyroidism showed a median rate in the 2 study
periods of 10 patients and 8 patients operated on for
Graves disease per year (pat/y) (P = not significant
Table 1.
Indication for thyroid surgery over the entire observation study
period
Number Percentage
Initial operation 3,904
Benign nodular goiter 2,568 66
Hyperthyroidism 796 20
Malignancies 540 14
Operation for recurrence 445
Benign nodular goiter 349 78
Hyperthyroidism 22 5
Malignancies 74 17
Total operations 4,349
Total nerves at risk 5,785
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[NS]). Toxic adenoma (8 vs. 3 pat/y in each period
[P = 0.02]) and toxic nodular goiter (8 vs. 9 pat/y
[P = NS]) were the 2 other reasons for hyperthyroidism
leading to operations. The subgroups of malignant goiter
disease, such as papillary thyroid cancer (PTC), follicular
thyroid cancer (FTC), and other malignancies, showed
similar yearly occurrence in both study periods (PTC: 5
vs. 10 pat/y in each period [P = 0.01]; FTC: 6 vs. 5 pat/y
per period [P = 0.04]; others: 4 vs. 4 pat/y per period
[P = NS]). The indications for surgery were the same in
both study periods, namely, growing thyroid nodules,
suspected malignancy, mechanical disturbances, and in
a few cases cosmetic reasons (asymmetry, size of the
tumor).
As is usual in a teaching hospital, various surgeons
performed the operations during the study periods. A staff
surgeon supervised the operations in all cases. Intraop-
erative frozen sections were taken and histological anal-
yses of thyroid tissue were performed in every patient and
directly influenced the extent of surgery.
During the first study period (1972–1990), following
Kochers recommendation, mainly subtotal thyroid
resections (leaving a remnant of thyroid tissue of > 8 ml)
or merely enucleations of thyroid nodules (in order to
avoid dependence on thyroid hormone substitution) were
performed (80%; Fig. 1). Less than 20% of the operations
before 1990 involved complete lobectomies (hemithyroi-
dectomies).
From 1991 onward, the surgical approach was more
extensive: in patients with strictly unilateral thyroid dis-
ease a lobectomy was performed on the affected side.
Most of the patients, however, presented with nodules in
both thyroid lobes, where a bilateral lobectomy was per-
formed, unless macroscopically normal thyroid tissue
could be left in place on one side, in which case a subtotal
resection (leaving 2–4 ml of thyroid tissue) was per-
formed on one side and a complete lobectomy on the
contralateral side (Fig. 1).
Defined surgical technique was performed in both
study periods without modifications.13–16 A staff surgeon
was present in all operations in both study periods. In
contrast to the first study period (1972–1990), the
recurrent laryngeal nerves and the parathyroid glands
were obligatorily visualized during the second period,
from 1991 to 2002. In the case of accidental devascu-
larization of the parathyroid gland the parathyroid was
transplanted in the sternocleidomastoid muscle. Perma-
nent recurrent laryngeal nerve palsy rates (defined as
persistence of palsy for more than 6 months) and rates
of permanent hypoparathyroidism (defined as persis-
tence of hypocalcemia for more than 6 months) were
analyzed. Indications for reoperative thyroid gland sur-
gery were mechanical disturbances, compression of the
trachea, rapid thyroid growth, or suspicion of malig-
nancy. ANOVA was used to analyze linear regression
models, and post-tests were done with the Kruskal–
Wallis method. Hypothesis testing was performed with
Fishers exact test using Number Cruncher Software
(NCSS, Kaysville, UT, USA). Significance levels were
set at a P value of £ 0.05.
Table 2.
The 2 observation periods are similar with regard to the frequency of operations and the etiology of the underlying diseases
Operations/year Intergroup difference
1972–1990 1991–2002
Median (LL–UL) % Median (LL–UL) % Significance (P value)
Operations total (n = 4,349) 161 (100–174) 130 (114–137) NS
Nerves at risk (n = 5,785) 195 (132–217) 181 (180–206) NS
Primary operations (n = 3,904) 143 (92–57) 89 118 (109–124) 92 NS
Benign nodular goiter (n = 2,568) 100 (70–109) 66 67 (60–83) 63 NS
Hyperthyroidism (n = 796) 25 (19–34) 21 23 (16–31) 20 NS
Malignant goiter (n = 540) 17 (13–20) 13 22 (11–23) 16 NS
Operations for recurrence (n = 445) 17 (10–20) 11 10 (8–13) 8 0.002
Benign nodular goiter (n = 349) 13 (8–16) 76 8 (6–10) 79 NS
Hyperthyroidism (n = 22) 1 (0–1) 6 1 (0–1) 6 NS
Malignant goiter (n = 74) 3 (1–3) 18 1 (1–3) 15 NS
NS: Statistically not significant.
The table compares the median operations performed per year in each time period. Values in parentheses represent the lower
and upper limits of the 95% confidence interval. Percentages given refer to the total of each category. Hyperthyroidism and
malignant goiter are sub-categorized in the text. P values were calculated using the Mann–Whitney U test and significance levels
were set at P < 0.05.
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RESULTS
Injury of the Inferior Laryngeal Nerve (Recurrent
Laryngeal Nerve)
Analyzing the 2,867 thyroid interventions with 3,488
nerves at risk in the first study period, from 1972 to 1990,
we noticed that the recurrent laryngeal nerve palsy rate
was 3.6% (105 out of 2,925) for primary operations and
5.3% (30 out of 563) for interventions treating recurrent
disease (Table 3). Comparing these data with the results
from the second period, 1991–2002 (with obligatory
visualization of the recurrent laryngeal nerve and the
parathyroid glands), which included 1,482 thyroid opera-
tions with 2,297 nerves at risk, we found a significant
decrease in the recurrent laryngeal nerve palsy rate to
0.9% (20 out of 2,128; P < 0.001; Table 3). This reduc-
tion in nerve lesions corresponds to a relative risk
reduction (RRR) of 74% and an absolute risk reduction
(ARR) of 2.66%. Hence, every 38th patient would profit
from the more extended operation (number needed to
treat [NNT] = 38 patients). The laryngeal nerve palsy rate
after surgery for thyroid disease recurrence decreased
non-significantly from 5.3% to 4.7% (8 out of 169) from
the first to the second observation period.
To evaluate if differences between the 2 observation
groups (1972–1990 and 1991–2002) arose from an un-
known effect over time, we performed a subgroup analysis
of the variation of the rate of laryngeal nerve palsy within
the observation time. Figure 2 shows the box-plot of lar-
yngeal nerve injuries in 5 (6)-year intervals, confirming that
changes did indeed occur between 1990 and 1991 rather
than over the period before or after the change of tech-
nique. A time effect would be noticeable by a tendency of
the intervals toward lower palsy rates over time. Post-test
analysis with the Kruskal–Wallis test showed a significant
difference between the intervals of the first observation
period and the second period (P = 0.005).
Hypoparathyroidism
The incidence of permanent hypoparathyroidism (>1
year) at the initial operations was 3.2% (93 out of 2,867)
for the first study period and 0.6% (9 out of 1,482) for the
second (P < 0.01; Table 3). Hence, our data show,
somewhat unexpectedly, that postoperative permanent
hypoparathyroidism was significantly less frequent after
the more extended operation (with obligatory visualization
of the parathyroid glands). The relative risk reduction
(RRR) was 81%, corresponding to an ARR of 2.6%, which
translates into an NNT of 38, so that again, in every 38th
patient hypoparathyroidism could be avoided by the
radical approach.
Incidence of Reoperation for Disease
Recurrence
The number of patients who were referred to our insti-
tution for reoperation due to thyroid disease recurrence
declined over the study periods (Fig. 3A). The incidence
of reoperations decreased from 11.1% (319 out of 2,867)
in the first study period to 8.5% (126 out of 1,482) in the
second period (P = 0.007). Analysis of recurrent disease
rates over both observation periods by linear regression
Figure 1. Schematic drawing of the amount of thyroid tissue
resected before and after 1991. In unilateral disease (top), a
subtotal thyroid resection that left significant tissue behind
(> 8 ml) was performed in the first study period (1970–1990),
whereas a hemithyroidectomy (lobectomy) with resection of the
isthmus and the lobus pyramidalis was performed in the second
study period and the laryngeal nerve (dotted line) as well as both
parathyroid glands were exposed (1991–2002). Bi-lobar disease
(bottom) was treated with bilateral subtotal thyroidectomy or
cyst enucleation before 1991 and with hemithyroidectomy plus
contralateral lobectomy or an extended subtotal resection (near-
total resection)—if macroscopically normal tissue could be left in
place—after 1991.
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showed that the incidence remained stable over the first
study period (1972–1990; P = 0.73), whereas a trend to-
ward a decreased incidence was found in the second
study period (P = 0.09; Figs. 2C, 3B). Because follow-up
cannot be guaranteed to be complete, we performed a
case-cohort analysis with a calculated odds ratio (OR) of
0.74 (95% CI: 0.59–0.92), which showed a 1.3 times
higher risk for patients from the earlier study period (1972–
1990) who needed reoperation.
DISCUSSION
Morbidity of Extensive Surgery
Concern that a more extensive surgical approach to
(nodular) goiter would increase peri- and postoperative
morbidity has been raised by endocrinologists and sur-
geons alike, especially in countries where medico-legal
issues are of concern. In this prospective cohort study we
found that extensive surgical thyroid resections lead to a
significant reduction in surgical morbidity compared with
limited (subtotal) resection: in our study populations the
recurrent laryngeal nerve palsy rate dropped 4-fold from
3.6% in the subtotal hemi-thyroidectomy group to 0.9% in
the complete hemi-thyroidectomy group. These findings
correlate with the data of a large meta-analysis on
recurrent laryngeal nerve palsy associated with thyroid
surgery. The meta-analysis compared visualization of the
recurrent laryngeal nerve (which is necessary in total
thyroidectomy) to ‘‘blind,’’ subtotal thyroid resections
without visualization of the recurrent laryngeal nerve
during thyroid gland surgery. It showed a significant
reduction in palsy rates from 6.1% in the ‘‘blind’’ group to
2.5% in the ‘‘visualized’’ group.17–19 Interestingly, the
percentage decrease in the rate of nerve lesions at our
institution (75%) was even higher than the rate in the
meta-analysis (59%). Routine intraoperative visualization
of the laryngeal nerve and the parathyroid glands (as
performed in the second study period) as well as con-
tinually improving anatomical knowledge of the perform-
ing surgeon, probably both, contributed to this reduction
in postoperative laryngeal nerve palsy in extensive goiter
Table 3.
Morbidity of thyroid surgery
1972–1990 1991–2002 Relative risk (CI 95% LL–UL)
Thyroid operations 2,867 1,482
Nerves at risk 3,488 2,297
First resection 2,925 2,128
Resection for recurrence 563 169
Recurrent nerve palsy
Primary surgery 105 3.6% 20 0.9%* 0.26 (0.16–0.43)
Recurrent surgery 30 5.3% 8 4.7%
Hypoparathyroidism 93 3.2% 9 0.6%* 0.19 (0.09–0.38)
95% CI: 95% confidence interval, LL: lower limit, UL: upper limit (of 95% confidence interval).
*P < 0.001
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Figure 2. Subgroup analysis for laryngeal nerve palsy rate over
the years. Nerve lesions remained at similar levels within the
observed groups (1972–1990/1991–2002). The box-plot dia-
gram depicts the rate of nerve lesions during each 5 (6)-year
interval. The horizontal lines within the box represent the
median, and boxes give the interquartile range (IQR) of 50%
(upper: 75%, lower: 25%). T-bars are given for the 75% plus 1.5
times the IQR and 25% minus 1.5 times the IQR respectively.
Whereas groups within the observation periods (1972–1990 and
1991–2002) did not differ significantly from each other, groups
from the first period had a significantly higher incidence of nerve
lesions after primary surgery than the 2 groups treated with the
total hemithyroidectomy approach (P = 0.005; Kruskal–Wallis
test).
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surgery.20–23 This perfection of surgery could also be
reflected in the 5-fold drop in the postoperative hypo-
parathyroidism rate from 3.2% to 0.6% (P < 0.001).
An additional advantage of a more extensive surgical
strategy is that expensive, time-consuming preopera-
tive imaging studies–scintigraphy, MRI, CT scans (con-
traindicated when postoperative radio-iodine-therapy is
considered)—become redundant. In most cases preop-
erative sonography will be sufficient.
It is of interest to note that other pioneers of thyroid
surgery were already advocating the complete lobectomy
with visualization of the recurrent laryngeal nerve as the
gold standard in the 1970s. However, this complete
resection was performed in only a few centers, mainly in
the USA, and it was not considered ‘‘standard therapy’’
for benign thyroid disease in most centers due to lack of
reliable data. However, nowadays, surgeons in the USA
specialized in endocrine surgery increasingly prefer the
more extensive approach as described in this study.
Especially in regions where goiter disease is endemic, the
historically grown approach of limited resection is still
quite widespread.
Incidence of Disease Recurrence
Despite the elimination of iodine deficiency the inci-
dence of goiter remained remarkably high in Switzer-
land. The astonishingly high incidence of recurrent goiter
necessitating secondary thyroid surgical treatment,
which is associated with significant morbidity was par-
ticularly bothersome. Conservative treatment with thy-
roid hormones to prevent goiter recurrence after subtotal
thyroidectomy showed only limited efficacy.24–29 The
endocrinology research department of the University of
Bern has recently described the molecular biological
phenomenon that epithelial cells of the thyroid could
alter their phenotype during a patients life. These
changes in the phenotype are followed by clonal growth
leading to functional as well as morphologic polymor-
phism that has the potential to occur anywhere in the
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Figure 3. Rates of operations for recurrent thyroid disease over time. A. Rate of patients operated on for recurrent thyroid disease
per year. Dot-plot with linear regression line of the rate of recurrent thyroid operations each year. Dots mark the rates and the line
represents the linear regression model. P values are calculated by one-way ANOVA. During the whole observation period the
incidence for reoperations declined significantly. B. Rate of reoperation for recurrent disease during the first observation period
(1972–1990). Linear regression shows little difference in the rate of reoperations over time. C. Rate of reoperations for recurrent
disease during the second observation period (1991–2002). Despite the significant decrease in reoperation rates (from 11.1% to
8.5%) between the 2 study periods (P = 0.007), the slope of the linear regression model shows no significance, but a tendency
toward decreased rates of reoperation is evident. The slope served to verify the continuing decrease in reoperations in the second
period, which will, likely, reach significance in time.
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whole thyroid tissue. The episodic replication of these
multiple clusters (nodular growth) seems to be depen-
dent on the over-expression of growth factors (JgF, EgF,
RAS). 24,30–32 Thus, it is tempting to speculate that
reducing the amount of cells that have the potential of
clonal morphological change surgically would reduce the
incidence of disease recurrence. The findings of the
present study confirm that a more extensive surgical
approach can reduce the incidence of recurrent goiter
significantly (from 11.1% to 8.5%; P = 0.007).13 This
more extensive approach includes the total resection of
all nodular thyroid tissue with at least a lobectomy
(hemithyroidectomy) on one side and, if indicated by the
existence of bilateral nodular disease, a total or subtotal
lobectomy on the contralateral side. However, we have
to acknowledge that the duration of the observational
period (12 years) is rather short, because disease may
recur even after 20 years.
Surgery for Recurrent Disease
The newly gained molecular knowledge in the patho-
genesis of goiter could explain why 78% of the recur-
rences in this study were seen in euthyroid benign
goiters. Reoperations for recurrent thyroid disease har-
bor the potential for significant morbidity.13,18,19 That is
why redo surgery is often delayed until the clinical sit-
uation has worsened so much that a second surgical
intervention is inevitable. The possibility of reducing the
chance of goiter recurrence by doing an extended thy-
roid resection at the initial operation, as described in this
study, thus offers an obvious advantage. This approach
also lessens the risk of laryngeal nerve lesions at a
subsequent operation for recurrent disease because
only one side and often unresected (untouched) side will
have to be explored. Hence, complete thyroidectomy on
the diseased side will not only directly reduce morbidity
at the first operation, but it will also reduce the incidence
of recurrent disease and its risky re-explorations. In
addition, only one side will be exposed to potential nerve
and parathyroid damage if a reoperation should be
necessary. Thus, lobectomy instead of subtotal thyroid-
ectomy at the initial operation reduces the risk of sig-
nificant morbidity at 3 different levels. As mentioned in
the previous paragraph, given the not insignificant inci-
dence of recurrent goiter disease, patients with any
nodular disease on the contralateral side should be
encouraged to proceed with near-total thyroidectomy or
more complete resection.
Drawback of the More Extensive Surgical
Approach
The more extensive resection of thyroid tissue com-
pared with subtotal thyroidectomy or enucleation alone,
would be expected to increase in the requirement for
hormonal substitution therapy.
Preliminary analysis of our data show that postopera-
tive substitution with thyroid hormones is, indeed, pre-
scribed in 50%–75% of patients treated with the more
extensive approach. However, it is extremely difficult to
assess whether substitution is indicated for all these pa-
tients because postoperative management of patients
operated for goiter remains in the hands of general
practitioners. Unfortunately, many still believe that goiter
recurrences can be prevented by thyroid hormone treat-
ment, which they therefore prescribe to all patients who
have undergone goiter surgery, independent of their
thyroid metabolic state.
Statistical Considerations
In this cohort study we prospectively analyzed 2 popu-
lations treated for thyroid disease for morbidity associated
with the intervention. A major concern of non-concurrent
studies, in general, is the influence of time-dependent
factors not accounted for. Thus, we evaluated the 2 groups
for differences in additional factors that could influence the
outcome (Table 2). Because during both observation
periods the frequency and indications for thyroid surgery
remained identical, we assumed that no changes in referral
patterns or discrepancies in the rate of disease entities
occurred. Furthermore, analysis of time-dependent factors
showed a constant rate of laryngeal nerve lesions within
the 2 observation periods (1972–1990 and 1991–2002;
Fig. 3), further indicating that the strongly significant dif-
ferences between the two groups are mainly due to the
change in surgical technique rather than to an unknown
effect over time. Ninety-nine percent of the patients were
prospectively followed for postoperative recurrent lar-
yngeal nerve lesions and hypoparathyroidism. However,
only patients referred to our clinic were included in the
analysis of goiter recurrence. The probability that patients
with recurrent disease were lost to follow-up because they
were referred to clinics other than the single specialized
referral center for thyroid disease in the region is quite
small. Considering the low probability of committing a type I
error, we therefore suggest that the observed difference in
recurrence rates is due to the change in the treatment
strategy.
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CONCLUSION
The data presented in this study support the recom-
mendation to perform at least a 1-sided lobectomy com-
bined with either total or subtotal thyroidectomy of the
contralateral side if indicated at the initial operation for
benign thyroid disease. Hence, Theodor Kochers ‘‘Gold
standard’’ (subtotal resections or enucleations without
perioperative visualization of the recurrent laryngeal
nerve or the parathyroids) would be no longer advisable.
The more extensive approach (with visualization of the
recurrent laryngeal nerve and the parathyroid glands) is
based on the newly gained knowledge of goitrogenesis as
a molecular biological and genetic disease. It not only has
the advantage of minimizing the remaining thyroid tissue
and, hence, reducing the number of clones that have the
potential to recur, but also to significantly reduce the rate
of recurrent laryngeal nerve lesions as well as to avoid
postoperative hypoparathyroidism. Hence, a reduction in
overall morbidity of the surgical treatment of goiter can be
seen:
1. At the level of reduced morbidity of the initial operation
2. At the reduction in goiter recurrence
3. At the level of decreased morbidity in the case of
recurrent thyroid disease: if reoperation is required the
risk of potential bilateral nerve damage is avoided, as
the resection will be limited to 1 side only
However, our data do not allow postoperative hypothy-
roidism to be analyzed, requiring hormone substitution,
due to the more extensive approach advocated here.
Interestingly, the extensive surgical resection to benign
thyroid disease was the initial intention of Theodor Ko-
cher when he conducted his first study involving over 100
thyroidectomies in 1883. At that time untreatable post-
operative hypothyroidism and hypoparathyroidism com-
bined with anesthesiologic difficulties forced him to
advocate his ‘‘criterion standard’’ of subtotal resection
that would stand for a century.1 Today, however, based
on the knowledge gained in goitrogenesis and based on
the significantly reduced morbidity shown in this study,
the time has come to advocate his initial intention of
extensive resection as the ‘‘gold standard’’ in the surgical
treatment of benign thyroid disease.
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